Chemoinformaics analysis of 11,13-dihydrotaraxin acid-beta-d-glucopyranosyl-ester
| Molecular Weight | 426.462 | nRot | 3 |
| Heavy Atom Molecular Weight | 396.222 | nRig | 22 |
| Exact Molecular Weight | 426.189 | nRing | 3 |
| Solubility: LogS | -2.528 | nHRing | 2 |
| Solubility: LogP | 0.96 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 0 |
| nHA | 9 | APOL | 62.2918 |
| nHD | 4 | BPOL | 37.0402 |
| QED | 0.361 |
| Synth | 5.169 |
| Natural Product Likeliness | 2.916 |
| NR-PPAR-gamma | 0.012 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.15 |
| Pgp-sub | 0.866 |
| HIA | 0.986 |
| CACO-2 | -5.374 |
| MDCK | 0.000111203 |
| BBB | 0.153 |
| PPB | 0.744207 |
| VDSS | 1.282 |
| FU | 0.188992 |
| CYP1A2-inh | 0.062 |
| CYP1A2-sub | 0.067 |
| CYP2c19-inh | 0.024 |
| CYP2c19-sub | 0.27 |
| CYP2c9-inh | 0.013 |
| CYP2c9-sub | 0.331 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.104 |
| CYP3a4-inh | 0.242 |
| CYP3a4-sub | 0.137 |
| CL | 4.181 |
| T12 | 0.711 |
| hERG | 0.042 |
| Ames | 0.102 |
| ROA | 0.207 |
| SkinSen | 0.315 |
| Carcinogencity | 0.045 |
| EI | 0.011 |
| Respiratory | 0.261 |
| NR-Aromatase | 0.349 |
| Antiviral | Yes |
| Prediction | 0.593303 |